CACNA1C and schizophrenia: A previous GWAS demonstrated that rs4765905 in CACNA1C reached genome-wide significance in 16,374 cases with schizophrenia, schizoaffective disorder or bipolar disorder and 14,044 controls (p = 7.0×10−9) [10].